Clinical trial
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
NCT05440214 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 2, 2022
- Completion date
- December 30, 2026
- Enrollment
- 68 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
psychosis, suicide